Journal
HEART FAILURE REVIEWS
Volume 13, Issue 2, Pages 163-173Publisher
SPRINGER
DOI: 10.1007/s10741-007-9068-4
Keywords
noninvasive imaging; molecular imaging; apoptosis; cardiovascular; annexin
Categories
Funding
- NHLBI NIH HHS [K08 HL079984, K08 HL079984-03, UO1-HL080731, U01 HL080731] Funding Source: Medline
Ask authors/readers for more resources
Recent advances in molecular imaging have permitted the noninvasive imaging of apoptosis, a critical process underlying the pathogenesis of many diseases of the cardiovascular system including atherosclerotic vascular disease, myocardial ischemia and reperfusion injury, chronic heart failure, myocarditis, and cardiac allograft rejection. Multiple molecular targets including phosphatidylserine, phosphatidylinositol 3-kinase, and caspases have been targeted by a variety of imaging agents and modalities such as nuclear scintigraphy, PET, MRI, and fluorescent and bioluminescent imaging. Translationally, methods utilizing radiolabeled annexin V have proven promising in several clinical trials of ischemia-reperfusion injury and cardiac allograft rejection. New approaches using novel molecular imaging agents show great potential for the ability to image apoptosis in the research and clinical setting. Ultimately the ability to detect apoptosis noninvasively would help to identify patients for emerging anti-apoptotic therapies and guide clinical management with the aim of maximal myocardial preservation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available